{
    "id": 21345,
    "cites": 37,
    "cited_by": 17,
    "reference": [
        "Abadie, A., Diamond, A., & Hainmueller, J. (2010). Synthetic control methods for comparative case studies: Estimating the effect of California\u00c3\u00a2\u00e2\u0082\u00ac\u00e2\u0084\u00a2s tobacco control program. Journal of the American Statistical Association, 105(490).",
        "Abadie, A., Diamond, A., & Hainmueller, J. (2014). Comparative politics and the synthetic control method. American Journal of Political Science, forthcoming.",
        "Abadie, A., & Gardeazabal, J. (2003). The economic costs of conflict: A case study of the Basque Country. American Economic Review, 113-132.",
        "Anderson, D. M., Hansen, B., & Rees, D. I. (2013). Medical marijuana laws, traffic fatalities, and alcohol consumption. Journal of Law and Economics, 56(2), 333-369.",
        "Anderson, D. M., Hansen, B., & Rees, D. I. (2012). Medical marijuana laws and teen marijuana use (No. 6592 [Rev.]). IZA Discussion Papers.",
        "Bachhuber, M.A., Saloner, B., Cunningham, C.O., Barry, C.L. (2014). Medical Cannabis Laws and Opiate Analgesic Overdose Mortality in the United States, 1999-2010. JAMA Internal Medicine, August 25.",
        "Brady JE, Wunsch H, DiMaggio C, Lang BH, Giglio J and G Li (2014). Prescription Drug Monitoring and Dispensing of Prescription Opioids. Public Health Reports 129: 139-147.",
        "Borgelt LM, Franson KL, Nussbaum AM Wang GS (2013). The pharmacologic and clinical effects of medical cannabis. Pharmacotherapy 33: 195-209.",
        "Centers for Disease Control and Prevention, (2013a). Opioids drive continued increase in drug overdose deaths: Drug overdose deaths increase for 11th consecutive year. [Press Release].",
        "Centers for Disease Control and Prevention (CDC. \"Vital signs: overdoses of prescription opioid pain relievers and other drugs among women--United States, 1999-2010.\" MMWR. Morbidity and mortality weekly report 62.26 (2013b): 537.",
        "Centers for Disease Control and Prevention (2011). Vital Signs: Overdoses of Prescription Opioid Pain Relievers \u00c3\u00a2\u00e2\u0082\u00ac\u00e2\u0080\u009c United States, 1999-2008. Morbidity and Mortality Weekly Report. 60(43): 1487-1492.",
        "Centers for Disease Control and Prevention (CDC. (2009). Overdose deaths involving prescription opioids among Medicaid enrollees-Washington, 2004-2007. MMWR. Morbidity and Mortality Weekly report, 58(42), 1171.",
        "Choi, A. (2014, December). The Impact of Medical Marijuana Laws on Marijuana Use and Other Risky Health Behaviors. In Health & Healthcare in America: From Economics to Policy. Ashecon.",
        "Chriqui, JF; Pacula, RL; McBride, DC; Reichmann DA; VanderWaal CJ and Y Terry-McElrath (2002). Illicit drug policies: Selected laws from the 50 states and the District of Columbia, Berrien Springs, MI: Andrews University.",
        "DHHS (2013). Addressing prescription drug abuse in the United States: current activities and future opportunities. Atlanta: Centers for Disease Control and Prevention, 2013 (http://www .cdc.gov/homeandrecreationalsafety/overdose/hhs_rx_abuse.html).",
        "Finklea K, Bagalman E, Sacco L. Prescription Drug Monitoring Programs. Congressional Research Service, January 2013. http://www.fas.org/sgp/crs/misc/R42593.pdf (accessed September 2013).",
        "Gammaitoni AR, Fine P, Alvarez N, et al. (2003). Clinical application of opioid equianalgesic data. Clin J Pain 19:286 \u00c3\u00a2\u00e2\u0082\u00ac\u00e2\u0080\u009c97.",
        "Jones CM, Mack KA, Paulozzi LJ. (2013). Pharmaceutical overdose deaths, United States 2010. JAMA 20; 309(7): 657-659.",
        "Levi J, Segal LM, and AF Miller. (2013). Prescription Drug Abuse: Strategies to Stop the Epidemic 2013. Robert Wood Johnson Foundation Issue Report.",
        "Lynch ME, Cambell F (2011) Cannabinoids for treatment of chronic non-cancer pain; a systematic review of randomized trials. Br J Clin Pharmacol 72: 735-744.",
        "Lynne-Landsman, S. D., Livingston, M. D., & Wagenaar, A. C. (2013). Effects of state medical marijuana laws on adolescent marijuana use. American Journal of Public Health, 103(8), 1500-1506.",
        "Mark, T. L., Levit, K. R., Vandivort-Warren, R., Buck, J. A., & Coffey, R. M. (2011). Changes in US spending on mental health and substance abuse treatment, 1986\u00c3\u00a2\u00e2\u0082\u00ac\u00e2\u0080\u009c2005, and implications for policy. Health Affairs, 30(2), 284-292.",
        "Martin-Sanchez E, Furukawa TA, Taylor J, Martin JL (2009). Systematic review and metanalysis of cannabis treatment for chronic pain. Pain Med 10: 1353-1368.",
        "Murphy SL, Xu J and KD Kochanek (2013). \u00c3\u00a2\u00e2\u0082\u00ac\u00c5\u0093Deaths: Final Data for 2010\u00c3\u00a2\u00e2\u0082\u00ac\u00c2\u009d National Vital Statistics Report Vol. 61, No. 4: 1-118. May 8, 2013 NCHS. Multiple cause-of-death data, 1999\u00c3\u00a2\u00e2\u0082\u00ac\u00e2\u0080\u009c2013. CDC WONDER online database. 2014. Available from: http://wonder.cdc.gov/mcd.html.",
        "Nunberg, Helen; Kilmer, Beau; Pacula, Rosalie Liccardo; and Burgdorf, James R. (2011) \"An Analysis of Applicants Presenting to a Medical Marijuana Specialty Practice in California,\" Journal of Drug Policy Analysis: Vol. 4: Iss. 1, Article 1. DOI: 10.2202/1941-2851.1017 Pacula RL, Boustead A, and P Hunt (2014). \u00c3\u00a2\u00e2\u0082\u00ac\u00c5\u0093Words can be deceiving: A review of variation among legally effective medical marijuana laws in the United States\u00c3\u00a2\u00e2\u0082\u00ac\u00c2\u009d Journal of Drug Policy Analysis. ISSN (Online) 1941-2851, ISSN (Print) 2194-6337,DOI: 10.1515/jdpa-2014-0001, May 23 Pacula RL, Chriqui JF, Reichmann DA, & YM Terry-McElrath (2002). State medical marijuana laws: Understanding the laws and their limitations. Journal of Public Health Policy, 23(4), 413-439.",
        "Pacula RL, Powell D, Heaton P and E Sevigny (2015). \u00c3\u00a2\u00e2\u0082\u00ac\u00c5\u0093Assessing the Effects of Medical Marijuana Laws on Marijuana: The Devil is in the Details\u00c3\u00a2\u00e2\u0082\u00ac\u00c2\u009d Journal of Public Policy Analysis and Management. E-view ahead of print at: DOI: 10.1002/pam.21804 .",
        "Paulozzi LJ, Kilbourne EM, Desai HA (2011). Prescription drug monitoring programs and death rates from drug overdose. Pain Med 12: 747-754.",
        "Pletcher, M. J., Kertesz, S. G., Kohn, M. A., & Gonzales, R. (2008). Trends in opioid prescribing by race/ethnicity for patients seeking care in US emergency departments. JAMA, 299(1), 70-78.",
        "Reifler LM, Droz D, Bailey JE, Schnoll SH, Fant R, Dart DC, et al. (2012). Do prescription drug monitoring programs impact state trends in opioid abuse/misuse? Pain Med 13: 343-342.",
        "Sevigny, E. L., Pacula, R. L., & Heaton, P. (2014). The effects of medical marijuana laws on potency. International Journal of Drug Policy. 25(2): 308-319.",
        "Silva, J. S., & Tenreyro, S. (2006). The log of gravity. The Review of Economics and Statistics, 88(4), 641658.",
        "Simeone R and L Holland. 2006. An evaluation of prescription drug monitoring programs. Washington: Department of Justice (US), Office of Justice Programs.",
        "Substance Abuse and Mental Health Services Administration (SAMHSA), Drug Abuse Warning Network, 2011: National Estimates of Drug-Related Emergency Department Visits. HHS Publication No. (SMA) 134760, DAWN Series D-39. Rockville, MD: Substance Abuse and Mental Health Services Administration, 2013a.",
        "Substance Abuse and Mental Health Services Administration (SAMHSA), Results from the 2012 National Survey on Drug Use and Health: Summary of National Findings, NSDUH Series H-46, HHS Publication No.",
        "(SMA) 13-4795. Rockville, MD: Substance Abuse and Mental Health Services Administration, 2013b.",
        "Webster, Lynn R., et al. \"An analysis of the root causes for opioid\u00c3\u00a2\u00e2\u0082\u00ac\u00c2\u0090related overdose deaths in the United States.\" Pain Medicine 12.s2 (2011): S26-S35.",
        "Wen, H., Hockenberry, J. M., & Cummings, J. R. (2015). The effect of medical marijuana laws on adolescent and adult use of marijuana, alcohol, and other substances. Journal of health economics, 42, 64-80."
    ]
}